The National Institutes of Health (NIH) is launching a Phase 3 clinical trial to determine the efficacy of tecovirimat — the smallpox antiviral better known as TPOXX — for use in treating monkeypox, ...
Before this summer, monkeypox was practically unheard of in the U.S. But, now that the country has confirmed more than 7,500 cases, there are a lot of questions about monkeypox treatment. Here’s the ...
SIGA Technologies is a specialty pharmaceutical company that develops and sells antiviral medicines focused on biodefense. Its lead product, TPOXX, comes in oral and intravenous (IV) formulations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results